Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
- Clinical Testing Services Drive Revenue Growth of 153% Year-Over-Year to $4.3 Million -- Post-Quarter Close Cash Balance of $16.8 Million Includes Proceeds from Upsized Public Offering and Warrant Exercises -- Company to Hold Conference Call and Webcast Today, August 11, 2022, at 4:30 PM ET -STONY BROOK, N.Y.--(BU...
New York United States Stony Brook Jamesa Hayward Clinical Laboratory Evaluation Program Laboratory Developed Tests Ldts
Source: pharmiweb.com